Branched-chain ac-keto acid dehydrogense (BCKDH) complexes of lymphoblastoid cell lines derived from patients with classical maple syrup urine disease (MSUD) phenotypes were studied in terms of their catalytic functions and analyzed by immunoblotting, using affinity purified anti-bovine BCKDH antibody. Kinetic studies on three cell lines derived from patients with the classical phenotype showed sigmoidal or near sigmoidal kinetics for overall BCKDH activity and a deficiency of the El component activity.
Introduction
The branched chain amino acids leucine, isoleucine, and valine are catabolized through analogous mechanisms for the first three steps: transamination, oxidative decarboxylation of the branched-chain a-keto acid, and dehydrogenation ofthe resulting branched-chain acyl coenzyme A (CoA)' to enoyl CoA (1) . The oxidative decarboxylation of branched-chain a-keto acids is performed by a multienzyme complex, branched-chain a-keto acid dehydrogenase (BCKDH), which is associated with the mitochondrial inner membrane and composed of three catalytic components, i.e., branched-chain a-keto acid decarboxylase (El), dihydrolipoyl transacylase (E2) and dihydrolipoyl dehydrogenase (E3). The El component is further composed ofa(Eia) and fl(E1p) subunits (2) . El catalyzes both the decarboxylation ofthe a-keto acid and the subsequent reductive acylation ofthe lipoyl moiety Presented at the 29th Annual Meeting ofthe Japanese Society ofInherited Metabolic Disease in Nagoya, October 1986, and at the 6th International Neonatal Screening Symposium, Austin, TX November 1986.
1. Abbreviations used in this paper: BCKDH, branched-chain a-keto acid dehydrogenase; El, decarboxylase component of BCKDH; E,,., asubunit of El; Ells, #-subunit of El; E2, acyl-transferase component of BCKDH; E3, dihydrolipoyl dehydrogenase; PDH, pyruvate dehydrogenase; MSUD, maple syrup urine disease.
that is covalently bound to E2. E2 catalyzes a transfer ofthe acyl group from the lipoyl moiety to coenzyme A (3, 4) . The E3 component is a flavoprotein and reoxidizes the reduced lipoyl sulfur residues of E2. The El and E2 components are specific for the BCKDH complex, whereas the E3 component is identical to that associated with the pyruvate and a-ketoglutarate dehydrogenase complexes (5) . These enzyme components presumably catalyze a coordinate sequence of reactions constituting the overall reaction, similar to the mechanism elucidated for the pyruvate dehydrogenase (PDH) complex, as follows (3).
R-CO-COOH + CoA-SH + NAD+ -. R-CO-S-CoA + CO2 + NADH + H+. The BCKDH complex activity is deficient in patients with maple syrup urine disease (MSUD).
Currently, four different phenotypes have been distinguished, on the basis of the clinical features; classical (6, 7), intermittent (8, 9) , intermediate (10) , and thiamine-responsive types (11) . The enzyme activities in cultured skin fibroblasts are much lower in the classical than in other types accompanied by a milder clinical course (12) . Chuang et al. carried out detailed studies and observed the activities of the El, E2, and E3 components, separately, in a disrupted cultured skin fibroblast preparation.
They proposed that the high affinity component of El was deficient in classical cases of MSUD (13) . Danner et al. reported another classical case of E2 deficiency, demonstrated using the immunoblotting method (14) . The genetic heterogeneity of MSUD was also demonstrated in studies involving genetic complementation analysis (15) (16) (17) . E3 deficiency was clearly detected in patients together with elevated blood levels ofboth branchedchain a-keto acids and pyruvate (18, 19) . Although MSUD is one of the most common inborn errors of metabolism, first detected by Menkes et al. (6) , fundamental knowledge of the biochemical and genetic mechanisms involved in this disease is lacking. We established lymphoblastoid cell lines from patients with different types ofthis disease as these cells have advantages for studying biochemical genetics (20) (21) (22) (23) (24) Preparation ofthe BCKDH (El and EJ and PDH complexes from bovine tissue. The BCKDH (El and E2) complex was purified from bovine kidney, basically as described by Lawson et al. (32) . The prepared sample was further subjected to sucrose density gradient centrifugation. The density gradient was formed from 15 ml of 10% sucrose in 30 mM potassium phosphate, pH 7.4/0.1 mM EGTA/0.2 mM phenylmethylsulfonyl fluoride/5 mM 2-mercaptoethanol (buffer C) and 15 ml of 30% sucrose in buffer C on a layer of 50% sucrose in buffer C (5 ml) placed at the bottom. After centrifugation in a rotor (RPS 27-2, Hitachi Corp., Tokyo, Japan) for 12 h at 18,000 rpm, the gradient was fractionated into 1-ml aliquots. The fractions showing BCKDH activity were combined, and the complex was collected by centrifugation at 180,000 g for 3.5 h. (33) , and the maximum specific activity of the enzyme was determined to be 3.8 U/mg protein.
Preparation ofantibodies against bovine BCKDH, the PDH complex and pig dihydrolipoyl dehydrogenase. Antibody was raised in a female New Zealand White rabbit by injecting 100 ,g of the purified BCKDH complex mixed with Freund's complete adjuvant into the lymph nodes of the hind legs (34) . 2 wk after the fifth injection, blood was obtained from the marginal ear vein. The serum was divided into small aliquots and kept frozen at -750C until use. A similar regimen was followed for the preparation of the anti-bovine PDH complex and pig dihydrolipoyl dehydrogenase.
Preparation ofaffinity purified antibodies against the bovine kidney BCKDH complex. An affinity column was prepared with the bovine BCKDH complex as the bound ligand. The procedure for coupling the ligand to CNBr-activated Sepharose was as follows. The gel matrix (0.3 g) was activated and washed according to the manufacturer's instructions. Approximately 0.5 mg of the ligand was bound to the gel matrix. The gel was packed into a column (1 X 1 cm), and the preparation washed with 1 M NaCl, 10 mM sodium phosphate, pH 7.2, and 150 mM NaCl, 10 mM sodium phosphate, pH 7.2, alternatively several times. The gel was further washed with 0.5 M NaCQ, 0.1% Tween 20, 50 mM sodium phosphate, pH 7.5 (buffer D). The rabbit anti-bovine BCKDH complex serum was loaded onto the affinity column repeatedly. The affinity gel was extensively washed with buffer D, and then eluted with 0.1 M Na2CO3. The immunoglobulin fractions were neutralized to an apparent pH of 7-8 with 5 M HCI. The fractions were pooled, dialyzed against 150 mM NaCl, 10 mM sodium phosphate, pH 7.2, and then concentrated with a collodion bag (Sartorius, West Germany). The antibody was used within 3 mo.
Immunotitration ofthe BCKDH and PHD complexes. We used the direct immunotitration method, in which a constant amount of an enzyme is incubated with various amounts of a monospecific antibody (35) . In the control incubation, the same amount of nonimmune immunoglobulin was incubated with the BCKDH complex.
Immunotitration of the PDH complex was performed by the method of Matuda et al. (33) .
SDS-PA;GE. Electrophoretic analysis of proteins was carried out on 10% (wt/vol) polyacrylamide-gel slabs with a 5% (wt/vol) stacking gel, using the discontinuous buffer system of Laemmli (36) and a Bio-Rad apparatus (Protean dual slab cell, Bio-Rad Laboratories, Richmond, CA).
Protein blot analysis. BCKDH immunoreactive protein in cultured cell extracts was detected after SDS-PAGE. The gel was soaked for 30 min in 25 mM Tris, 190 mM glycine, pH 8.3. EdI&troblotting was performed in an Bio-Rad electroblot apparatus (Trans-Blot Cell, Tokyo, Japan) onto nitrocellulose, according to the manufacturer's instructions. After the electrophoretic transfer, the blot (nitrocellulose paper with inmmobilized proteins) was soaked in 100 ml of buffer E (150 mM NaCI, 10 mM sodium phosphate buffer, pH 7.2, containing 1% gelatin and 0.1% Tween 20) for 1 h at 40°C. After rinsing with buffer F (150 mM NaCl, 10 mM sodium phosphate buffer, pH 7.2, containing 0.25% gelatin and 0.1% Tween 20) for i h, the protein blot was incubated overnight at room temperature with shaking in 100 ml of buffer F containing 200 M1 ofthe specific anti-BCKDH complex antibody. After incubation with the antibody, the blot was washed three times for 20 iin each with 200 ml ofbuffer F. The protein blot was then incubated with 100 ml ofbuffer F containing 300 Ml of peroxidase-conjugated swine immxnoglobulins to rabbit immunoglobutins for I h, with shaking. The blot was washed as described above. Peroxidase activity was detected using freshly prepared 4-methoxy-l-naphthol (I ml of a 1% methanol solution in 50 ml of 50 mM Tris-HC1, pH 7.4) plus 50 Ml of 30% H202. Spectrophotometrically, the activity ofthe bovine BCKDH complex was assayed at 300C in the presence of excess dihydrolipoyl dehydrogenase (E3) as described (3) . One unit of enzyme catalyzes the formation of 1 limol NADH per min (3) . Radiochemical assaying ofthe BCKDH activity Preparation ofa radiolabeled substrate. a-Keto [1-4C]isovaleric acid is unstable under the storage conditions used and is contaminated by volatile radioactive compounds. Because it is necessary to use a substrate with a high specific activity at low substrate concentrations, we modified the radioactive substrate preparation to obtain more precise kinetic data. Volatile radioactive contaminants were removed from the substrate before incubation, as described for radioactive branched-chain amino acids by Dancis et al. (12) . Immediately before use, the radioactive substrate was dissolved in deionized water and nitrogen was bubbled through the solution for 30 min on ice. The solution was then shaken for 1 h at room temperature in a test tube connected to a mini-counting vial with a thick rubber tube, containing filter paper (Whatman Inc., Clifton, NJ, 4 X 5 cm) immersed in 0.2 ml of 20% fl-phenethylamine in methanol. With this procedure, the radioactive contaminants were fairly well minimized. The volume of the radioactive substrate solution was appropriately adjusted with deionized water. Approximately 0.1 ACi of radioactive aketoisovaleric acid was used per assay, with the addition of the nonradioactjve substrate to obtain various specific activities.
BCKDH overall assay. The activity ofBCKDH (overall) was assayed as described (13, 37) using a disrupted lymphoblastoid cell suspension, except that calf serum was omitted. The assay mixture contained a disrupted cell suspension (equivalent to 0.8-1.0 mg) in 0.05 ml ofDulbecco's Ca2+, Mg2+ free phosphate buffer solution and a-keto[l-'4C]isovaleric acid (-0.1 Ci) in a final volume of 0.37 ml. The reaction was carried out at 350C in a test tube connected to a mini-counting vial with a thick rubber tube, as described by Ichiyama et al. (38) . The vial contained a filter paper strip that was immersed in 0.2 ml of 20% 0-phenethylamine in methanol. After equilibration for 1 min, the reaction was started by addition of the labeled substrate. At the end of incubation, 0.1 ml of 15% trichloroacetic acid was injected through the rubber tube. This acidified reaction mixture was then left to stand for I h at 350C to remove the residual "4CO2. After incubation, 7 ml of a scintillation cocktail (Scintisol EX-H) was added to the vial to determine the radioactivity. All kinetic data were obtained in duplicate. In all experiments, a duplicate blank incubation was carried out, for which all the ingredients, except the disrupted cell suspension, were used. The blank value was within I to 4% ofthe total sample counts, which ranged from 2,000 to 7,000 dpm for normal lymphoblastoid cells, depending on the substrate concentration. The nonenzymatic evolution of 14C02 was subtracted from the value obtained with the experimental incubation. The activity of frozen cells was stable for at least 3.5 mo at -750C.
Assay for the El component. The radiochemical assay used was essentially that described by Chuang et al. (13) (Fig. 1) . The Vm. and apparent Km values were 13-15 nmol per h/mg of protein and 0.05-0.06 mM, respectively. In contrast, cells from MSUD subjects showed two different kinetic patterns (Fig. 2) . One group A showed hyperbolic kinetics for BCKDH over the substrate concentration of 0.05-2.0 mM, whereas group B exhibited sigmoidal kinetics or near sigmoidal kinetics. The group A cell lines were derived from intermittent MSUD patients (K.F., R.F.) and GM 1366. The group B ones were from classical MSUD patients (K.Y., Y.T.) and GM 1655. Both group A and B showed significantly reduced enzyme activities measured at 2.0 mM or lower (0.054 mM) substrate concentration (P < 0.01), which corresponds to the apparent Km value of the highly purified bovine BCKDH complex (42) . The enzyme activities in group A were higher than those in group B at 2.0 mM (P < 0.01) or 0.054 mM (P < 0.01) substrate concentration. Fig. 3 a is a Lineweaver-Burk plot for the BCK.DH complex. The apparent Kms for R.F., K.F., and GM 1366 were 0.067, 0.123, and 0.097 mM, respectively. The same plots for K.Y., Y.T., and GM 1655 showed no linearity.
In contrast, Hill plots (Fig. 3 b) showed that the concentration of substrate needed for half-maximal velocity (K0.5) was 0. Immunotitration ofbovine BCKDH complex activity with a specific antibody. Immunoglobulin from a rabbit sensitized with the highly purified bovine kidney BCKDH (El + E2) complex specifically inhibited the catalytic activity of this enzyme complex, when NADH production was measured by means of the overall assay for the enzyme complex. 50% inhibition of the activity occurred in the presence of the antibody at a ratio of 1.2:1 (immunoglobulin/BCKDH, wt/wt), when 2.0 Mug of BCKDH protein (5 U/mg ofprotein) was used (data not shown).
Antiserum prepared against pig heart dihydrolipoyl dehydrogenase (E3) was tested in terms of catalytic inhibition of the enzyme. 50% inhibition was observed when 2 Mg of bovine BCKDH protein (2 U/mg) and 2 'U of pig dihydrolipoyl dehydrogenase were incubated in the presence of 5 Ml ofthe antiserum against E3 (data not shown).
Immunotitration of bovine PDH complex activity with the antiserum. 50% inhibition occurred when 35 Mg ofPDH protein (1.3 U/mg of protein) was incubated with 20 Ml of the prepared antiserum against the PDH complex. Immunoblotting. As shown in Fig. 5 , similar antigen peptide patterns were observed in all except lane 2, which contained the bovine PDH complex. The three main immunogenic peptides were, in decreasing size, the E2 (Mr 52,000), El. (Mr 46,000), and Eld (Mr 37,000) peptides of the BCKDH complex. The bovine PDH complex on the nitrocellulose blot was not recognized by the anti-BCKDH complex immunoglobulin. The antibody raised against the bovine BCKDH complex could detect crossreacting peptides of the human tissues. The three peptides were similar in size to the corresponding bovine BCKDH peptides.
The E3 peptide was also identified on immunoblots, using the antibody against pig heart dihydrolipoyl dehydrogenase (data not shown).
To delineate the molecular basis for the low BCKDH activity in MSUD lymphoblasts, enzymes were studied, using anti-bovine BCKDH complex immunoglobulin. This experiment was performed at the same time and under the same condition, except for lane 7. A typical immunoblot is shown in Fig. 6 , in which three antigenic proteins corresponding to E2, E,<, and E1,, of purified bovine kidney BCKDH were clearly stained, and two additional bands, besides the latter, were seen for both normal and MSUD cell lines. Since these bands did not appear in case of the purified bovine BCKDH complex, the origin of these E2 -I EK--a Elp~N proteins is unknown. All three cell lines (K.Y., Y.T., and GM 1655) derived from classical MSUD patients lacked a single antigenic protein that corresponded to the E1, subunit ofBCKDH.
In addition, a protein corresponding to Ela was weakly stained in all, particularly in the K.Y. cell line.
In contrast, an antigenic protein that corresponded to the E2 component was moderately reduced in the R.F. cell line derived from an intermittent type patient, and the protein was absent in the GM 1366. Another cell line (K.F.) contained three proteins.
To rule out the possibility of an artifact from Epstein-Barr virus transformation, we compared the BCKDH complex of lymphoblastoid cells and skin fibroblasts derived from the same patients. As shown in Fig. 7 , the same structural abnormalities of BCKDH complex were observed in two MSUD subjects, determined using both lymphoblastoid cells and skin fibroblasts. We also noted absence of the E2 protein in the GM 612 skin fibroblast, as a reference, since the observation was described by Eisenstein et al. (43) .
In all the cell lines examined, the E3 peptide, which is similar in size to porcine dihydrolipoyl dehydrogenase, was identified on immunoblots (data not shown).
We also studied the PDH complex, using rabbit antibodies raised against the bovine heart enzyme, as a reference for the mitochondrial multienzyme complex. Fig. 8 shows the immunoblot pattern of the PDH complex on SDS-PAGE. Similar antigen peptide patterns were observed for all the cell lines examined. The six main immunogenic peptides were, in decreasing size, dihydrolipoyl transacetylase, dihydrolipoyl dehydrogenase, X, the a-subunit of pyruvate dehydrogenase, Y, and the #-subunit of pyruvate dehydrogenase. An additional band, X, that migrated below the E3 component, was consistently found in the purified preparation ofthe complex, when the electrophoretic analysis was performed using Laemmli's buffer system, as noted previously by Stanley and Perham (44) . The extra band, Y of undetermined origin, was seen only when immunoblotting was performed.
Discussion
The BCKDH complexes derived from patients with two different MSUD phenotypes were studied in terms oftheir catalytic functions (substrate dependent kinetics) and the properties of the Figure 5 . Immunoblots of the BCKDH complex. method (14) . 
